HAS : A Novel Anti-cancer Drug Prepared from SEC SuperantigenHAS : A Novel Anti-cancer Drug Prepared from SEC Superantigen(Abstract) Chen Ting -zuo(Chengdu Institute of Biological Products ,Chengdu 610063 , P.R.China ) 1. Clinical Observations HAS is a nov